Scientific Reports · Nov 17, 2026
Progressive Whole-body vibration plus exercise is associated with quality-of-life gains without detectable inflammatory changes in sarcopenic older adults
By Altaf S, Malmir K, Mir SM et al.
Sarcopenia is associated with reduced quality of life and chronic low-grade inflammation. Whole-body vibration (WBV) training offers a gentler alternative to strenuous exercise for older adults, but its effects on sarcopenia-specific QoL, inflammation, and potential sex-specific differences remain unclear. This study examined whether progressive WBV combined with active exercise could improve these outcomes in older adults with sarcopenia. In this assessor-blinded trial, 60 sarcopenic adults (≥ 60 years) were randomized into control and intervention groups, stratified by sex. Four participants withdrew after the baseline assessment, leaving 56 participants in the final analysis. The intervention group (14 men, 14 women) performed active exercises combined with vibration at increasing frequencies (15–40 Hz) over 8 weeks. The control group (14 men, 14 women) performed the same exercises without vibration. Sarcopenia Quality of Life (SarQoL), IL-6 (Interleukin-6), and ESR (Erythrocyte Sedimentation Rate) were measured before, after 8 weeks of intervention, and at 8 weeks follow-up. No time × group × sex interaction remained significant after Holm adjustment (largest unadjusted effect: ADLs, F(1.576, 81.962) = 3.83, p = 0.035; Holm-adjusted p = 0.352; ηp² = 0.069). Overall time × group effects remained significant for Physical and Mental Health (Holm-adjusted p < 0.001), Locomotion (0.042), Functionality (< 0.001), ADLs (< 0.001), Leisure Activities (< 0.001), Fears (0.001), and Total SarQoL (< 0.001), but not for Body Composition, IL-6, or ESR. In sex-stratified analyses, significant effects remained in men for Physical and Mental Health (0.032), Functionality (< 0.001), and Total SarQoL (0.008), and in women for Physical and Mental Health (0.001), Locomotion (0.008), Functionality (0.006), ADLs (< 0.001), Leisure Activities (< 0.001), Fears (0.014), and Total SarQoL (< 0.001). These findings were descriptive and did not establish a sex-dependent treatment effect. At post-intervention and follow-up, 100% of WBV participants versus 78.6% and 64.3% of controls, respectively, achieved the selected 9-point Total SarQoL responder threshold. No significant intervention effects were detected for IL-6 or ESR. Progressive WBV combined with active exercise was associated with greater improvements in several sarcopenia-specific quality-of-life outcomes than active exercise alone, while the primary analysis did not demonstrate a statistically significant sex-dependent differential response. No statistically significant additional change in IL-6 or ESR was detected. The 9-point threshold was used as a responder threshold rather than as a universally established MCID. Larger studies with longer follow-up are needed to clarify the added value of WBV, the durability of quality-of-life changes, and possible biological effects on inflammation in older adults with sarcopenia.